Literature DB >> 9391246

Incidence of Crohn's disease in Stockholm County 1955-1989.

A Lapidus1, O Bernell, G Hellers, P G Persson, R Löfberg.   

Abstract

AIM: To evaluate the incidence of Crohn's disease in Stockholm County between 1955 and 1989.
METHODS: A cohort of 1936 patients with Crohn's disease was retrospectively assembled. Incidence rates and changes in disease distribution were assessed.
RESULTS: The mean increase in incidence was 15% (95% confidence intervals 12% to 18%) per five year period with a mean annual incidence rate at 4.6/10(5) during the last two decades. The mean incidence for the entire study period was similar for men and women. The mean age at diagnosis increased from 25 years in 1960-64 to 32 years in 1985-89, partly because of an increasing proportion of patients aged at least 60 years at diagnosis. The proportion of patients with colonic Crohn's disease at the time of diagnosis increased from 15% to 32% (17% difference; 95% confidence intervals 12% to 23%) whereas the proportion of patients with ileocaecal disease decreased from 58% to 41% (17% difference; 95% confidence intervals 10% to 24%) during the study period. Elderly patients had a higher proportion of small bowel disease and a lower proportion of ileocolonic disease compared with the younger patients.
CONCLUSION: The incidence rate of Crohn's disease in Stockholm has stabilised at 4.6/10(5) and the proportion of elderly patients has increased during a 35 year period. Colonic Crohn's disease has increased in frequency with a reciprocal decrease in ileocaecal disease.

Entities:  

Mesh:

Year:  1997        PMID: 9391246      PMCID: PMC1891542          DOI: 10.1136/gut.41.4.480

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

2.  Inflammatory bowel disease and tobacco smoke--a case-control study.

Authors:  P G Persson; A Ahlbom; G Hellers
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

4.  Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway.

Authors:  K Haug; E Schrumpf; J F Halvorsen; G Fluge; E Hamre; T Hamre; R Skjøllingstad
Journal:  Scand J Gastroenterol       Date:  1989-12       Impact factor: 2.423

5.  Cardiff Crohn's disease jubilee: the incidence over 50 years.

Authors:  J D Rose; G M Roberts; G Williams; J F Mayberry; J Rhodes
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

6.  Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis.

Authors:  G Hellers
Journal:  Acta Chir Scand Suppl       Date:  1979

7.  Has smoking changed the epidemiology of ulcerative colitis?

Authors:  C Tysk; G Järnerot
Journal:  Scand J Gastroenterol       Date:  1992-06       Impact factor: 2.423

8.  Crohn's disease in the city of Derby, 1951-85.

Authors:  I W Fellows; J G Freeman; G K Holmes
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

9.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

10.  Epidemiology of Crohn's disease in Regio Leiden, The Netherlands. A population study from 1979 to 1983.

Authors:  S Shivananda; A S Peña; M Nap; I T Weterman; J F Mayberry; E J Ruitenberg; P J Hoedemaeker
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

View more
  29 in total

1.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Association of age at diagnosis and ulcerative colitis phenotype.

Authors:  Sandra M Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

3.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 4.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

Review 5.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 6.  Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

Authors:  Irene Modesto; Giovanni Perricone; Ambrogio Orlando; Mario Cottone
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

7.  Inflammatory bowel disease incidence: up, down or unchanged?

Authors:  R F Logan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

8.  Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants.

Authors:  Michael Economou; Grigoris Filis; Zoi Tsianou; John Alamanos; Antonios Kogevinas; Kostas Masalas; Anna Petrou; Epameinondas V Tsianos
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

9.  Prevalence of gastrointestinal diseases in two British national birth cohorts.

Authors:  A G C Ehlin; S M Montgomery; A Ekbom; R E Pounder; A J Wakefield
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

10.  The ulcerative colitis marker protein WAFL interacts with accessory proteins in endocytosis.

Authors:  You Fu Pan; Ing-Marie Viklund; Heng Hang Tsai; Sven Pettersson; Ichiro N Maruyama
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.